Join us to commemorate the 30-year anniversary of the first medicine approved in U.S. to treat HIV.
A new immersive theater experience co-created with and about Black gay men in Baltimore, Maryland, and Jackson, Mississippi
Learn how the Jacksonville Area Sexual Minority Youth Network (JASMYN) is making a difference in young adults’ lives.
As the only company solely focused on HIV, we go beyond developing new medicines. We take a holistic approach to HIV by developing and supporting sustainable community programs — with and for the HIV community.
ViiV Healthcare has a long-standing commitment to activities that deliver education, treatment and prevention and access to care through on-the-ground programs.
The voice of the HIV community informs everything we do to improve the lives and health outcomes of all people living with HIV.
ViiV Healthcare Announces FDA Approval of SELZENTRY® (maraviroc) for Use in Children and Adolescents Living With HIV
ViiV Healthcare extends Medicines Patent Pool licence agreement for dolutegravir to cover all lower middle-income countries
ViiV Healthcare announces first phase II HIV prevention study results for investigational long-acting injectable cabotegravir
We must stand together to reduce disparities in communities disproportionately impacted by HIV, with the goal of leaving no person living with HIV behind.
Read how to report a side effect.
The people and models used on this website are merely illustrative of people living with HIV, and this website is not intended to imply that they have HIV.
©2017 ViiV Healthcare group of companies. All rights reserved. ViiV Healthcare US, Five Moore Drive, Research Triangle Park, North Carolina USA, 27709-3398.